∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
---|---|---|---|---|
ASI - AGENZIA SPAZIALE ITALIANA |
NEuroendocrine-metabolic-inflammatory and infection-proneness Profile Testing before and after long-term UNderwater and Extraterrestrial missions (NEPTUNE ISS-PP)
|
|
Ongoing | 2021 |
ASI - AGENZIA SPAZIALE ITALIANA |
WOUND HEALING AND SKIN RECONSTRUCTION IN UNLOADING CONDITIONS -Gravity-related Restore Of Wound and Skin (GROWS)
|
|
Ongoing | 2021 |
ASI - AGENZIA SPAZIALE ITALIANA |
NEuroendocrine-metabolic-inflammatory and infection-proneness Profile Testing before, during and after short-term UNderwater and Extraterrestrial missions (NEPTUNE ISS-SDM)
|
|
Ongoing | 2021 |
ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
New strategies to enhance the trophic functions and remyelinating abilities of adult NG2-glia in amyotrophic lateral sclerosis via the GPR17 receptor (GPR17ALS-1)
|
|
Ongoing | 2020 |
CAR_RIC - Bandi Fondazione Cariplo |
Molecular mechanisms of T regulatory impairment in Familial Hypercholesterolemia: exploring cellular metabolic reprogramming as a tool to restore their
suppressive function
|
|
Ongoing | 2020 |
CAR_RIC - Bandi Fondazione Cariplo |
Synapse-to-nucleus signalling in Alzheimer's disease
|
|
Ongoing | 2020 |
CAR_RIC - Bandi Fondazione Cariplo |
Dissecting the role of anti-GluA3 antibodies in Frontotemporal Dementia: from bench to bedside
|
|
Ongoing | 2022 |
CAR_RIC - Bandi Fondazione Cariplo |
Role of CHIP/STUB1 in the clearance of toxic proteins responsible for repeat expansion neurodegenerative diseases
|
|
Ongoing | 2022 |
FON_NAZ - Bandi Altre Fondazioni |
A new role for exosomes in prostate cancer microenvironment: exploring the cross-talk between adipocytes and tumor cells (3° anno)
|
|
Ongoing | 2022 |
H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia (RECOGNISED)
|
|
Ongoing | 2020 |
H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
Twinning towards excellence in alternative methods for toxicity assessment (TWINALT)
|
|
Ongoing | 2020 |
H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
The impact of early life stress in later life (EarlyCause)
|
|
Ongoing | 2022 |
Horizon Europe - Marie Skłodowska-Curie actions - Doctoral Networks (DN) |
FuEl ThE bRaiN In healtThY aging and agE-relateD diseases (ETERNITY)
|
|
Ongoing | 2023 |
Horizon Europe - Marie Skłodowska-Curie actions - Doctoral Networks (DN) |
Metal-containing Radical Enzymes (MetRaZymes)
|
|
Ongoing | 2022 |
Horizon Europe Global Challenge-RIA/IA/CSA |
Next generation advanced RNA inhibition therapy to treat cardiometabolic disease (LiverTarget)
|
|
Ongoing | 2022 |
Horizon Europe Global Challenge-RIA/IA/CSA |
Understanding, predicting, and treating depression in pregnancy to improve mothers and offspring mental health outcomes (HappyMums)
|
|
Ongoing | 2022 |
INTLI - Finanziamenti internazionali |
Exploring the Impact of Nanoplastics on Sexual Reproduction by Applying Tailored In Vitro Models of Developing and Maturing GnRH Neurons
|
|
Ongoing | 2022 |
INTLI - Finanziamenti internazionali |
Dissecting the role of Zc3h10 in adipose tissues: a new player in type 2 diabetes onset/progression
|
|
Ongoing | 2020 |
JPI_MIUR - Joint Programming Initiatives_MIUR |
Unveiling the Role of Glutamate in dopaminE traNsporTer deficiency Syndrome (URGENT)
|
|
Ongoing | 2020 |
MIS - Bandi Ministero Salute |
INNOVATIVE STRATEGIES FOR DEPRESSION TREATMENT: NOVEL PHARMACOLOGICAL TARGETS AND PRECLINICAL STUDIES FOR THE PERSONALIZATION OF THERAPY
|
|
Ongoing | 2009 |